Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  TEL AVIV STOCK EXCHANGE  >  Teva Pharmaceutical Industries Limited    TEVA   IL0006290147

 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Tel Aviv Stock Exchange
10/15/2017 10/16/2017 10/17/2017 10/18/2017 10/19/2017 Date
5308(c) 5240(c) 5184(c) 5152(c) 5145(c) Last
859 858 4 815 694 1 016 490 611 725 628 546 Volume
-4.72% -1.28% -1.07% -0.62% -0.14% Change
More quotes
Financials ($)
Sales 2017 22 644 M
EBIT 2017 6 282 M
Net income 2017 -
Debt 2017 34 451 M
Yield 2017 -
Sales 2018 20 624 M
EBIT 2018 5 050 M
Net income 2018 -
Debt 2018 27 776 M
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales2017 2,17x
EV / Sales2018 2,06x
Capitalization 14 723 M
More Financials
Company
Teva Pharmaceutical Industries Ltd. is a global pharmaceutical company, which provides patient-centric healthcare solutions.It operates through two segments: Generic Medicines and Specialty Medicines.The Generic Medicines segment includes chemical and therapeutic equivalents of originator medicines... 
Sector
Pharmaceuticals
Calendar
11/02 | 12:00pmEarnings Release
More about the company
Latest news on TEVA PHARMACEUTICAL INDUST
10/20 TEVA PHARMACEUTICAL INDUSTRIES LIMIT : DEADLINE MONDAY: Levi & Korsinsky, LLP Re..
10/19 TEVA PHARMACEUTICAL INDUSTRIES LIMIT : DEADLINE MONDAY: Lundin Law PC Announces ..
10/19 TEVA PHARMACEUTICAL INDUSTRIES : to Report Third Quarter 2017 Financial Results ..
10/19 TEVA PHARMACEUTICAL INDUSTRIES LIMIT : The Law Offices of Vincent Wong Reminds I..
10/19 TEVA PHARMACEUTICAL INDUSTRIES : Announces Submission of Biologics License Appli..
10/19 TEVA PHARMACEUTICAL INDUSTRIES : to Highlight New Data in Multiple Sclerosis at ..
10/18 TEVA REMINDER DEADLINE ALERT : The Law Offices of Howard G. Smith Reminds Invest..
10/18 TEVA PHARMACEUTICAL INDUSTRIES LIMIT : APPROACHING DEADLINE: Khang & Khang LLP A..
10/18 TEVA PHARMACEUTICAL INDUSTRIES LIMIT : Levi & Korsinsky, LLP Reminds Shareholder..
10/17 TEVA PHARMACEUTICAL INDUSTRIES LIMIT : DEADLINE ALERT: Lundin Law PC Announces a..
More news
Sector news : Pharmaceuticals - NEC
10/20DJMERCK AND : to Lay Off About 1,800 U.S. Sales Reps in Cost-Cutting Move
10/20 MERCK AND : to cut 1,800 U.S. sales jobs, add 960 in chronic care
10/20DJABBOTT LABORATORIES : Hacking Is a Risk for Pacemakers. So Is the Fix
10/19DJCELGENE : Halts Crohn's Disease Drug Trials
10/19DJEuropean Corporate Roundup for Thursday
More sector news : Pharmaceuticals - NEC
Latest Tweets
02:51aTeva Pharmaceutical Industries Limited $TEVA Given a $17.00 Price Target by C.. 
10/19Teva Pharmaceutical Industries Limited given $17.00 PT by Cantor Fitzgerald. .. 
10/19INVESTOR ALERT: Goldberg Law PC Announces a Securities Class Action Lawsuit a.. 
10/18Goldberg Law PC Announces a Securities Class Action Lawsuit against Teva Phar.. 
10/18Private Asset Management Inc. Has $572,000 Holdings in Teva Pharmaceutical In.. 
More tweets
Qtime:106
News from SeekingAlpha
10/20 Debt-laden pharmas under pressure on Concordia's debt restructuring
10/19 J&J : Unattractive
10/18 TEVA BULLS ARE TOO EARLY : Debt Downgrade On The Way
10/18 YOUR DAILY PHARMA SCOOP : AZN's Imfinzi SBLA; Ablynx U.S. IPO; Is Teva A Buy?
10/18 HEALTHCARE DOGFIGHT : Owens & Minor Edges GlaxoSmithKline As Top Broker Pick For..
Chart TEVA PHARMACEUTICAL INDUST
Duration : Period :
Teva Pharmaceutical Indust Technical Analysis Chart | TEVA | IL0006290147 | 4-Traders
Technical analysis trends TEVA PHARMACEUTICAL INDUST
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Average target price 28,0 $
Spread / Average Target 92%
Managers
NameTitle
Kåre Schultz President & Chief Executive Officer
Sol J. Barer Chairman
Carlo de Notaristefani President & CEO-Global Operations
Michael McClellan Chief Financial Officer
Michael R. Hayden Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
TEVA PHARMACEUTICAL INDUSTRIES LIMITED-62.38%14 891
JOHNSON & JOHNSON23.29%377 585
NOVARTIS13.50%226 453
ROCHE HOLDING LTD.5.55%215 760
PFIZER11.58%213 372
MERCK AND COMPANY7.88%173 214